Revumenib

60 interactions 3 explained in plain English
Also sold as: Revuforj
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Oxaliplatin Injection Alfuzosin Felbamate Lenvatinib Arsenic Trioxide Dofetilide
60 Major
All (60) Major (60)

Major

Revumenib Amitriptyline Elavil Explained An increased risk of QT interval prolongation Details Revumenib Sertraline Explained An increased risk of QT interval prolongation Details Revumenib Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Revumenib Amisulpride Injection Barhemsys An increased risk of QT interval prolongation Details Revumenib Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Revumenib Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Revumenib Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Revumenib Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Revumenib Azithromycin AzaSite An increased risk of QT interval prolongation Details Revumenib Alfuzosin UroXatral An increased risk of QT interval prolongation Details Revumenib Anagrelide Agrylin An increased risk of QT interval prolongation Details Revumenib Bedaquiline Sirturo An increased risk of QT interval prolongation Details Revumenib Chloroquine Aralen® An increased risk of QT interval prolongation Details Revumenib Dasatinib Phyrago An increased risk of QT interval prolongation Details Revumenib Degarelix Injection Firmagon An increased risk of QT interval prolongation Details Revumenib Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Revumenib Disopyramide Norpace An increased risk of QT interval prolongation Details Revumenib Dofetilide Tikosyn An increased risk of QT interval prolongation Details Revumenib Dolasetron Anzemet An increased risk of QT interval prolongation Details Revumenib Dolasetron Injection Anzemet An increased risk of QT interval prolongation Details Revumenib Encorafenib Braftovi An increased risk of QT interval prolongation Details Revumenib Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Revumenib Eribulin Injection Halaven An increased risk of QT interval prolongation Details Revumenib Famotidine Calmicid An increased risk of QT interval prolongation Details Revumenib Famotidine Injection Calmicid An increased risk of QT interval prolongation Details Revumenib Felbamate Felbatol An increased risk of QT interval prolongation Details Revumenib Flecainide Tambocor® An increased risk of QT interval prolongation Details Revumenib Foscarnet Injection Foscavir An increased risk of QT interval prolongation Details Revumenib Galantamine Razadyne An increased risk of QT interval prolongation Details Revumenib Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation Details Revumenib Gemifloxacin Factive An increased risk of QT interval prolongation Details Revumenib Glasdegib Daurismo An increased risk of QT interval prolongation Details Revumenib Goserelin Implant Zoladex An increased risk of QT interval prolongation Details Revumenib Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation Details Revumenib Granisetron Injection Granisol An increased risk of QT interval prolongation Details Revumenib Histrelin Implant Supprelin An increased risk of QT interval prolongation Details Revumenib Hydroxychloroquine Plaquenil An increased risk of QT interval prolongation Details Revumenib Inotuzumab Ozogamicin Injection Besponsa An increased risk of QT interval prolongation Details Revumenib Ivabradine Corlanor An increased risk of QT interval prolongation Details Revumenib Lefamulin Xenleta An increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.